BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Biofuel
,
Aspirin
,
rs2230926
,
KLK3
,
T cell differentiation
,
Allergy to pollen
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
toll like receptor 5
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Macrophage RAW264.7 cells with IKK knockdown or treatment with p38 inhibitor
Blood of C5 deficient patient in response to E. coli with complement and CD14 inhibition
Wild-type and p38a-knockout dendritic cells stimulated with Pam3CSK4
The anti-inflammatory nature of HDL in macrophages
Whole blood samples from healthy donors stimulated in vitro with Pam3CSK4 or LPS
Explore Curated Studies Results
Literature
Most Relevant Literature
Loss of toll-like receptor 5 potentiates spontaneous hepatocarcinogenesis in farnesoid X receptor-de…
Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice.
Toll-like receptor 5 knock-out mice exhibit a specific low level of anxiety.
Evading the Toll booth: How "silent" flagellins may bind yet fail to activate TLR5.
Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Suppression of Toll Like Receptors by Insulin
A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients
Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis
Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% as a New Surrogate Model of Itc…
Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ